Business Description
Eupraxia Pharmaceuticals is a Canadian biotechnology company founded in 2011 and based in Victoria, British Columbia. The company has developed its own drug delivery technology, called Diffusphere, which is designed to release medication more effectively in the body. Its lead product is currently in a Phase III clinical trial for knee osteoarthritis, while other treatments targeting conditions of the digestive tract are at earlier stages of development.
